Related Experiment Video
Updated: Jun 17, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Abstract:
Reversible epigenetic changes that alter gene expression are a characteristic of many cancers and other diseases. Biotech companies are taking note and are starting to develop new drugs to reverse such pathogenic "epimutations."
Insights
Reversible epigenetic changes, known as epimutations, are hallmarks of various diseases. Biotechnology firms are developing novel therapeutics to correct these pathogenic alterations in gene expression.
Area of Science:
- Molecular Biology
- Genetics
- Epigenetics
Background:
- Epigenetic modifications, such as DNA methylation and histone alterations, play crucial roles in regulating gene expression.
- Aberrant epigenetic changes, termed epimutations, are increasingly recognized as significant contributors to the development and progression of various diseases, including cancer.
- These epimutations are potentially reversible, offering therapeutic opportunities.
Purpose of the Study:
- To highlight the role of reversible epigenetic changes in disease pathogenesis.
- To underscore the emerging therapeutic strategies targeting epimutations.
Main Methods:
- Review of current scientific literature on epigenetics and disease.
- Analysis of trends in biotechnology drug development focused on epigenetic targets.
Main Results:
- Epigenetic dysregulation is a common feature across a spectrum of human diseases.
- Biotechnology companies are actively investing in and developing drugs designed to reverse pathogenic epimutations.
- These novel drugs aim to restore normal gene expression patterns by targeting epigenetic mechanisms.
Conclusions:
- Reversible epigenetic modifications represent a critical area of research and therapeutic development.
- Targeting epimutations holds promise for treating a range of diseases characterized by altered gene expression.
More Related Videos
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
09:56Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
Published on: October 31, 2025
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...